GL1X · GenesisL1 explorer

Research workbench

Crystal structure of SARS-cov-2 main protease in complex with lon-wei- ADC59DF6-47

Analyse Crystal structure of SARS-cov-2 main protease in complex with lon-wei… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7NW2
Type
protein
Length
602 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
3C-like proteinase
EC
3.4.22.69
UniProt
P0DTC1
Ligands
USZ, CL
Pockets
5 · best druggability 0.77

Structure

x-ray diffraction · 1 distinct chain · 24% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B3C-like proteinase (EC 3.4.22.69)protein30124% helix, 30% strandP0DTC1

Ligands and binding sites

  • USZ · ~{N}-(4-~{tert}-butylphenyl)-~{N}-[(1~{R})-2-[2-(3-fluorophenyl)ethylamino]-2-oxidanylidene-1-pyridin-3-yl-ethyl]propanamide · ligand · chains A
  • CL · Chloride ion · ion · chains A
  • DMS · Dimethyl sulfoxide · additive · 9 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 3 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
110030.770.7983DMS
26320.680.77101DMS
32510.550.7731USZ
41610.480.7727empty
51670.430.7425DMS

Interfaces

1 interface between chains.

  • A–B · 1363 Ų buried · 35 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 7NW2 · Crystal Structure of SARS-CoV-2 main protease in complex with LON-WEI-adc59df6-47 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.